Yucel Aydin
Overview
Explore the profile of Yucel Aydin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
1603
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chava S, Ekmen N, Ferraris P, Aydin Y, Moroz K, Wu T, et al.
J Hepatocell Carcinoma
. 2024 May;
11:839-855.
PMID: 38741679
Introduction: Sorafenib, an FDA-approved drug for advanced hepatocellular carcinoma (HCC) treatment, encounters resistance in many patients. Deciphering the mechanisms underlying sorafenib resistance is crucial for devising alternative strategies to overcome...
2.
Koksal A, Ekmen N, Aydin Y, Nunez K, Sandow T, Delk M, et al.
J Hepatocell Carcinoma
. 2023 Nov;
10:1935-1954.
PMID: 37936599
Introduction: Extracellular vesicles could serve as a non-invasive biomarker for early cancer detection. However, limited methods to quantitate cancer-derived vesicles in the native state remain a significant barrier to clinical...
3.
Aydin Y, Gogokhia L, Ahmed S, Turan S, Shiferaw B
Cureus
. 2023 Aug;
15(7):e42317.
PMID: 37614268
Bezoars, characterized by undigested or partially digested foreign bodies in the gastrointestinal (GI) tract, are a rare condition associated with significant complications. We present a case of a 31-year-old woman...
4.
Aydin Y, Koksal A, Thevenot P, Nunez K, Elgamal M, Koksal U, et al.
Eur J Gastroenterol Hepatol
. 2023 Aug;
35(10):1224-1229.
PMID: 37577793
Background And Aims: Tumor-directed therapies (TDTs) are a constitutive part of hepatocellular carcinoma (HCC) treatment in patients awaiting liver transplantation (LT). While most patients benefit from TDTs as a bridge...
5.
Aydin Y, Vemuri B, Ahmed S, Elgamal M, Bilgin S
Cureus
. 2023 Aug;
15(7):e41536.
PMID: 37554613
Anaplasmosis, caused by the tick-borne bacterium , is an emerging infectious disease with a broad spectrum of clinical manifestations. Here, we present a case report of a 66-year-old Caucasian woman...
6.
Aydin S, Elgamal M, Aydin Y
Cureus
. 2023 Jul;
15(6):e40151.
PMID: 37425504
Subepithelial lesions (SELs) are common findings in the gastrointestinal (GI) tract. They are often benign and asymptomatic but can cause symptoms in some cases. The approach to endoscopic management of...
7.
Lin D, Chen Y, Koksal A, Dash S, Aydin Y
Cell Commun Signal
. 2023 May;
21(1):102.
PMID: 37158967
Background: Chronic hepatitis C virus (HCV) infection causes hepatocellular carcinoma (HCC). The HCC risk, while decreased compared with active HCV infection, persists in HCV-cured patients by direct-acting antiviral agents (DAA)....
8.
Wang J, Ghonim M, Ibba S, Luu H, Aydin Y, Greer P, et al.
J Transl Med
. 2022 Nov;
20(1):521.
PMID: 36348405
Background: We reported that PARP-1 regulates genes whose products are crucial for asthma, in part, by controlling STAT6 integrity speculatively through a calpain-dependent mechanism. We wished to decipher the PARP-1/STAT6...
9.
Koksal A, Thevenot P, Aydin Y, Nunez K, Sandow T, Widmer K, et al.
J Hepatocell Carcinoma
. 2022 Sep;
9:959-972.
PMID: 36105695
Background And Aim: HCC development in liver cirrhosis is associated with impaired autophagy leading to increased production of extracellular vesicles (EVs) including exosomes and microvesicles. The goal of the study...
10.
Aydin Y, Vemuri B, Gomez J, Challa P, Zhang H
Cureus
. 2022 Jul;
14(6):e25591.
PMID: 35795500
Coronavirus disease 2019 (COVID-19) continues to be fatal despite advances in the understanding of characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), global prevention strategies, new anti-viral treatments, and...